FindTrial
Sign In

STUDY ON THE EFFECT OF CITICOLINE VERSUS CALCIUM IN OSTEOPOROSIS.

COMPARITIVE STUDY ON THE EFFECT OF CITICOLINE VERSUS CALCIUM IN OSTEOPOROSIS.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/10/046318
Enrollment
100
Registered
2022-10-10
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M959- Acquired deformity of musculoskeletal system, unspecified

Interventions

Intervention1: oral administration of citicoline: one set of patients with osteoporosis will be given citicoline 1000mg every day of six months and compared with another group receiving calcium 1000mg

Sponsors

Pushpagiri Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Osteoporosis with T-Score below -2.5 SD 2. Patients on treatment for osteoporosis 3.Those willing to participate 4.Patients more than 60 years

Exclusion criteria

Exclusion criteria: 1.Smokers and Alcoholics not willing to stop the habits 2.Patients not tolerating citicoline and calcium 3.Patients on steroids and immunosuppresors 4.Diabetics, Renal and Hepatic failure 5.Immunodeficient patients

Design outcomes

Primary

MeasureTime frame
Improvement in BMD as shown by T scoreTimepoint: 3months 6months 9months 12 months—

Secondary

MeasureTime frame
disappearance of symptomsTimepoint: 3 months 6 months 9 months 12 months—

Countries

India

Contacts

Public ContactDrJohn PS

Pushpagiri Institute of Medical Sciences

drpsjohn@gmail.com9995060002

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026